Documentos de Académico
Documentos de Profesional
Documentos de Cultura
02b Fisiopatologia
02b Fisiopatologia
Bibliografa:
1.- Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the
International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999; 353: 1386
1389.
2.- Lapostolle F, Surget V, Borron SW, et al. Severe pulmonary embolism associated with air
travel. N Engl J Med. 2001; 345: 779783.
3.- Kearon C. Natural History of Venous Thromboembolism .Circulation 2003: 2003;107:I-22.
4.- Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous
thrombosis. N Engl J Med. 2003; 348: 14351441.
5.- William H. Geerts, MD, FCCP; Graham F. Pineo, MD; John A. Heit, MD; David Bergqvist,
MD, PhD; Michael R. Lassen, MD; Clifford W. Colwell, MD and Joel G. Ray, MD, MSc .The
Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy . Chest.
2004;126:338S-400S.
6.- Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 1. Thromb Haemost
1996; 76: 651-662.
7.- Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 2. Thromb Haemost
1996; 76: 824-834.
8.- Heit JA, Cohen AT, Anderson FA. Estimated annual number of incident and recurrent,
nonfatal and fatal VTE in the US. American Society of Hematology 47th Annual Meeting;
December 10-13, 2005; Atlanta, GA. Poster 910.
9.- Virchow, RLK Cellular pathology as based upon physiological and pathohistology. 7th
American ed. 1860,236 New York, NY. Chance F, DeWitt RM.
10.- Anderson FA, Jr; Spencer FA, MD Risk Factors for Venous Thromboembolism. Circulation.
2003;107:I-9
11.- Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous
thrombosis by perioperative administration of subcutaneous heparin. Overview of results of
randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988; 318: 1162
1173 .
12.- Kakkar VV, Howe CT, Nicolaides AN, et al. Deep vein thrombosis of the leg. Is there a
"high risk" group? Am J Surg. 1970; 120: 52753.
13.- Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and
pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000; 160: 809
815.
14.- Printen KJ, Miller EV, Mason EE, et al. Venous thromboembolism in the morbidly obese.
Surg Gynecol Obstet. 1978; 147: 6364.
15.- Hoibraaten E, Qvigstad E, Arnesen H, et al. Increased risk of recurrent venous
thromboembolism during hormone replacement therapyresults of the randomized, double-
blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET). Thromb
Haemost. 2000; 84: 961967.
16.- Danilenko-Dixon DR, Heit JA, Silverstein MD, et al. Risk factors for deep vein thrombosis
and pulmonary embolism during pregnancy or post partum: a population-based, case-control
study. Am J Obstet Gynecol. 2001; 184: 104110..
17.- Lieberman JS, Borrero J, Urdaneta E, et al. Thrombophlebitis and cancer. JAMA. 1961;
177: 542545.
18.- Rahr HB, Sorensen JV. Venous thromboembolism and cancer. Blood Coagul
Fibrinolysis. 1992; 3: 451460.
19.- Zangari M, Anaissie E, Barlogie B, et al. Increased risk of deep-vein thrombosis in patients
with multiple myeloma receiving thalidomide and chemotherapy. Blood. 2001; 98: 16141615.
20.- Osman K, Comenzo R, Rajkumar SV. Deep venous thrombosis and thalidomide therapy for
multiple myeloma. N Engl J Med. 2001; 344: 19511952 .
21.- Bowcock SJ, Rassam SM, Ward SM, et al. Thromboembolism in patients on thalidomide for
myeloma. Hematology. 2002; 7: 5153 .
22.- Clahsen PC, van de Velde CJH, Julien JP, et al. Thromboembolic complications after
perioperative chemotherapy in women with early breast cancer: a European Organization for
Research and Treatment of Cancer/Breast Cancer Cooperative Group Study. J Clin Oncol.
1994; 12: 12661271.
23.- Warlow C, Ogston D, Douglas AS. Venous thrombosis following strokes. Lancet. 1972; 1:
13051306.
24.- Kleber FX, Flosbach CW, Koppenhagen K. Comparison of the low molecular weight
heparin enoxaparin with unfractionated heparin in the prevention of venous thromboembolic
events in patients with heart failure NYHA III/IV (PRINCE II study). Circulation. 1999; 100 (Suppl
1): 1619.
25.- Svensson PJ, Dahlback, B. Resistance to activated protein C as a basis for venous
thrombosis. N Engl J Med. 1994; 330: 517522
26.- Ridker PM, Glynn RJ, Miletich JP, et al. Age-specific incidence rates of venous
thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med.
1997; 126: 528531
27.- Vandenbroucke JP, Koster T, Brit E, et al. Increased risk of venous thrombosis in oral-
contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994; 344: 1453
1457.
28.- De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous
thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin
mutation. N Engl J Med. 1999; 341: 801806.
29.- Pabinger I, Brucker S, Kyrle PA, et al. Hereditary deficiency of antithrombin III, protein C
and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational
patient screening. Blood Coagul Fibrinolysis. 1992; 3: 547553
30.- den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-
vein thrombosis. N Engl J Med. 1996; 334: 759762.
31.- den Heijer M, Rosendaal FR, Blom HJ, et al. Hyperhomocysteinemia and venous
thrombosis: a meta-analysis. Thromb Haemost. 1998; 80: 874877.
32.- Petri, M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun. 2000; 15:
145151
33.- Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002;
346: 752763.
34.- McGinn, S, White, PD Acute cor pulmonale resulting from pulmonary embolism. JAMA
1935;104,1473-1480.
35.- Dalen, JE, Haffajee, CI, Alpert, JS, et al Pulmonary embolism, pulmonary hemorrhage and
pulmonary infraction. N Engl J Med 1977;296,1431-14340.
36.- Dalen, JE Pulmonary Embolism: What Have We Learned Since Virchow?* Natural History,
Pathophysiology, and Diagnosis . Chest. 2002;122:1440-1456.
37.- Wood KW. Major Pulmonary Embolism. Review of a Pathophysiologic Approach to the
Golden Hour of Hemodynamically Significant Pulmonary Embolism. Chest. 2002;121:877-905.
38.- Esteban Prez-Rodrguez, MD; David Jimnez, MD; Gema Daz, MD; Ivan Prez-Walton,
MD; Manuel Luque, MD; Carmen Guilln, MD; Eva Maas, MD; Roger D. Yusen, MD .
Incidence of Air TravelRelated Pulmonary Embolism at the Madrid-Barajas Airport. Arch Intern
Med. 2003;163:2766-2770.
39.- Steve Goodacre, MB, ChB, FFAEM, MSc, PhD; Alex J. Sutton, BSc, MSc, PhD; and Fiona
C. Sampson, BA, MSc Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of
Deep Venous Thrombosis . Ann int Med: 2005; 143: 129-139.
40.- Wells, PS, Anderson, DR, Stiell, RM, et al Excluding pulmonary embolism at the bedside
without diagnostic imaging: management of patients with suspected pulmonary embolism
presenting to the emergency department by using a simple clinical model and d-dimer. Ann
Intern Med 2001;135,98-107.
41,. Samuel Z. Goldhaber, MD; C. Gregory Elliott, MD Acute Pulmonary Embolism: Part I
.Epidemiology, Pathophysiology, and Diagnosis . Circulation. 2003;108:2726.